Loading...

British Regulator First to OK Moderna’s Updated COVID Booster

August 15, 2022by Maria Cheng, Associated Press
British Regulator First to OK Moderna’s Updated COVID Booster
A vial of Moderna COVID-19 vaccine rests on a table at an inoculation station next to Jackson State University in Jackson, Miss., on July 19, 2022. (AP Photo/Rogelio V. Solis)

LONDON (AP) — British drug regulators have become the first in the world to authorize an updated version of Moderna’s coronavirus vaccine that includes protection against the omicron variant, which the government said would be offered to people aged 50 and over starting in the fall.

In a statement on Monday, the Medicines and Healthcare Regulatory Agency said it had given the green light to Moderna’s combination “bivalent” vaccine, which will be used as an adult booster shot.

Each dose of the booster shot will target both the original COVID-19 virus that was first detected in 2020 and the omicron BA.1 variant that was first picked up in November. British regulators said the side effects were similar to those seen for Moderna’s original booster shot and were typically “mild and self-resolving.”

“What this (combination) vaccine gives us is a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve,” said Dr June Raine, the head of Britain’s health care and medicines regulator.

British health secretary Steve Barclay said the new shot will be part of the country’s booster program roll-out from September, based on advice from the government’s vaccine experts.

“This safe and effective vaccine will broaden immunity and potentially improve protections against some variants as we learn to live with this virus,” Barclay said.

Such an approach, combining protection against several strains of the same disease is used with flu shots, which are adjusted each year depending on the variants that are circulating and can protect against four influenza strains.

Stephane Bancel, Moderna’s Chief Executive, said in a statement that it was the first regulatory authorization for a vaccine aiming to fight the omicron variant, predicting the booster would have an “important role” to play in protecting people against COVID-19 in the winter.

On Friday, Germany’s health minister said the European Medicines Agency might clear tweaked COVID-19 boosters next month.

In June, the U.S. Food and Drug Administration told vaccine makers that any booster shots tweaked for the fall would have to include protection against the newest omicron variants, meaning BA.4 and BA.5, not the BA.1 subvariant included in Moderna’s latest shot.

Last month, the FDA said it was no longer considering authorizing a second COVID-19 booster for all adults but would instead focus on revamped vaccines for the autumn that target the newest viral subvariants.

Both Moderna and Pfizer are currently brewing updated versions of their vaccine to include BA.5 in addition to the original COVID-19 virus.

According to the World Health Organization, the latest global surge of COVID-19 has been driven by omicron subvariant BA.5, which is responsible about 70% of the virus samples shared with the world’s largest public virus database. The subvariant BA.5 is even more infectious than the original version of omicron and has some genetic differences that earlier vaccines might not address.

Scientists have warned that the continued genetic evolution of COVID-19 means drugmakers will likely be one step behind the virus in their efforts to tailor their vaccines.

“The virus is unlikely to stand still and Omicron-targeted immunity, might push the virus down other evolutionary paths,” warned Jonathan Ball, a professor of virology at Britain’s University of Nottingham. Still, he said the new Moderna vaccine would likely still be protective against severe disease.

Other experts said it was still unknown how effective the new combination vaccine would be.

Beate Kampmann, director of the Vaccine Centre at London’s School of Hygiene and Tropical Medicine, said the shot would most likely only offer “partial protection” against the latest omicron variants including BA.5 since it was developed based on earlier versions of COVID-19.

“How much difference such (combination) vaccines can actually make remains to be seen,” she said, noting that the shots have not yet been widely tested in different populations.

 

In The News

Health

Voting

COVID-19

Pfizer Seeks to Expand Omicron Booster to 5- to 11-Year-Olds

(AP) -- Pfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to... Read More

(AP) -- Pfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to 11. Elementary school-aged children already received kid-sized doses of Pfizer’s original vaccine, a third of the dose given to everyone 12 and older -- two primary... Read More

August 19, 2022
by Eden Metzger
Kids Throw on Their Backpacks and Get the Vaccine

ROCHESTER, Minn. — Children aged 6 months and up are able to receive a vaccine just in time for the... Read More

ROCHESTER, Minn. — Children aged 6 months and up are able to receive a vaccine just in time for the first day of school. "We strongly encourage everyone to make sure their child is up to date with their COVID-19 vaccinations," said Dr. Nipunie Rajapakse, a... Read More

British Regulator First to OK Moderna's Updated COVID Booster

LONDON (AP) — British drug regulators have become the first in the world to authorize an updated version of Moderna's... Read More

LONDON (AP) — British drug regulators have become the first in the world to authorize an updated version of Moderna's coronavirus vaccine that includes protection against the omicron variant, which the government said would be offered to people aged 50 and over starting in the fall.... Read More

Biden Scraps Announcing Crime Plan After Positive COVID Test

WASHINGTON (AP) — President Joe Biden abruptly canceled a trip to Pennsylvania, where he had planned to propose a steep funding increase... Read More

WASHINGTON (AP) — President Joe Biden abruptly canceled a trip to Pennsylvania, where he had planned to propose a steep funding increase for police on Thursday, after testing positive for COVID-19. The Democratic president was set to ask Congress to spend roughly $37 billion for fighting and preventing crime — including... Read More

July 13, 2022
by Alexa Hornbeck
CDC Finds Threat of Antimicrobial Resistant Infections Worsened During Pandemic

ATLANTA — The U.S. Centers for Disease Control and Prevention released a report on Tuesday which examines how COVID-19 impacted... Read More

ATLANTA — The U.S. Centers for Disease Control and Prevention released a report on Tuesday which examines how COVID-19 impacted the progress of combating antimicrobial resistance, which occurs when changes in bacteria cause drug treatments to become less effective.   The nearly 50-page report finds that... Read More

US Failed to Stop Fraud in COVID Loan Program, Clyburn Says

The U.S. government failed to take basic steps at the beginning of the coronavirus pandemic to prevent fraud in a federal aid... Read More

The U.S. government failed to take basic steps at the beginning of the coronavirus pandemic to prevent fraud in a federal aid program intended to help small businesses, depleting the funds and making Americans more vulnerable to identity theft, the head of a congressional panel examining the payouts... Read More

News From The Well